$CBOE back near 6 month lows.
I'm keeping an eye on it ready to add to my long position:pic.twitter.com/HhRqiBVt7t
Show this thread
-
Imho not really. ICE? Nope (ellie mae, antitrust) NDAQ? Nope (antitrust) LSE? Nope (refinitiv) ENX? Nope (borsa italiana) DB1? Nope (antitrust) CME? Maybe, but nope (NEX) Only options are maybe Bloomberg or a PE firm. Not worth buying on M&A hopes alone
-
-
I'd have TMX on the long-shot list and generally not exclude possibility of more creative deal. Not sure why DB1 gets kicked out for reg reasons...CME/NEX seems pretty far along too. (pre-emptive cc
@BagholderQuotes on my behalf) -
DB1 is out for me bc of Xetra and they tried to buy NYSE way back when and got slapped away. CME doesn’t want cash equities imo but its in theory possible.
- Show replies
New conversation -
-
-
Wow things have gotten so bad we are looking for an acquirer? Yikes.pic.twitter.com/Nw8AALjk0q
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.